Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics
|
September 15, 2020
Population pharmacokinetics and pharmacodynamics of a novel vascular adhesion protein-1 inhibitor using a multiple-target mediated drug disposition model
Nelleke Snelder, Sven Hoefman, Alberto Garcia-Hernandez, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
September 15, 2020
Mechanism-based modeling of the effect of a novel inhibitor of vascular adhesion protein-1 on albuminuria and renal function markers in patients with diabetic kidney disease
Sven Hoefman, Nelleke Snelder, Martijn van Noort, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 8, 2023
Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery-Åsberg Depression Rating Scale
Marije E Otto, Kirsten R Bergmann, Marieke L de Kam, et al.
Therapeutic Drug Monitoring
|
July 12, 2021
Theoretical Performance of Nonlinear Mixed-Effect Models Incorporating Saliva as an Alternative Sampling Matrix for Therapeutic Drug Monitoring in Pediatrics: A Simulation Study
Matthijs D Kruizinga, Frederik E Stuurman, Gertjan J A Driessen, et al.
FEMS Microbiology Letters
|
November 19, 2011
Development of antibiotic resistance and up-regulation of the antimutator gene pfpI in mutator Pseudomonas aeruginosa due to inactivation of two DNA oxidative repair genes (mutY, mutM)
Lotte Frigaard Mandsberg, Maria D Maciá, Kirsten R Bergmann, et al.
British Journal of Clinical Pharmacology
|
November 23, 2021
Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populations
Matthijs D Kruizinga, Rob G J A Zuiker, Kirsten R Bergmann, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 21, 2020
Safety, pharmacokinetics, and pharmacodynamics of Gln-1062, a prodrug of galantamine
Charlotte Bakker, Jasper van der Aart, Ellen P Hart, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 14, 2023
Characterization of the Pharmacokinetic and Pharmacodynamic Profile of Apraglutide, a Glucagon-Like Peptide-2 Analog, in Healthy Volunteers
Federico Bolognani, Annelieke C Kruithof, Pascal Schulthess, et al.
Clinical and Translational Science
|
July 30, 2020
First Clinical Study with AP30663 - a K<sub>Ca</sub> 2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation
Pim Gal, Erica S Klaassen, Kirsten R Bergmann, et al.
Clinical Pharmacology and Therapeutics
|
January 29, 2022
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005
Mahdi Saghari, Pim Gal, Sally Gilbert, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Pharmacokinetics and Pharmacodynamics
|
September 15, 2020
Population pharmacokinetics and pharmacodynamics of a novel vascular adhesion protein-1 inhibitor using a multiple-target mediated drug disposition model
Nelleke Snelder, Sven Hoefman, Alberto Garcia-Hernandez, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
September 15, 2020
Mechanism-based modeling of the effect of a novel inhibitor of vascular adhesion protein-1 on albuminuria and renal function markers in patients with diabetic kidney disease
Sven Hoefman, Nelleke Snelder, Martijn van Noort, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 8, 2023
Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery-Åsberg Depression Rating Scale
Marije E Otto, Kirsten R Bergmann, Marieke L de Kam, et al.
Therapeutic Drug Monitoring
|
July 12, 2021
Theoretical Performance of Nonlinear Mixed-Effect Models Incorporating Saliva as an Alternative Sampling Matrix for Therapeutic Drug Monitoring in Pediatrics: A Simulation Study
Matthijs D Kruizinga, Frederik E Stuurman, Gertjan J A Driessen, et al.
FEMS Microbiology Letters
|
November 19, 2011
Development of antibiotic resistance and up-regulation of the antimutator gene pfpI in mutator Pseudomonas aeruginosa due to inactivation of two DNA oxidative repair genes (mutY, mutM)
Lotte Frigaard Mandsberg, Maria D Maciá, Kirsten R Bergmann, et al.
British Journal of Clinical Pharmacology
|
November 23, 2021
Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populations
Matthijs D Kruizinga, Rob G J A Zuiker, Kirsten R Bergmann, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
October 21, 2020
Safety, pharmacokinetics, and pharmacodynamics of Gln-1062, a prodrug of galantamine
Charlotte Bakker, Jasper van der Aart, Ellen P Hart, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 14, 2023
Characterization of the Pharmacokinetic and Pharmacodynamic Profile of Apraglutide, a Glucagon-Like Peptide-2 Analog, in Healthy Volunteers
Federico Bolognani, Annelieke C Kruithof, Pascal Schulthess, et al.
Clinical and Translational Science
|
July 30, 2020
First Clinical Study with AP30663 - a K<sub>Ca</sub> 2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation
Pim Gal, Erica S Klaassen, Kirsten R Bergmann, et al.
Clinical Pharmacology and Therapeutics
|
January 29, 2022
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005
Mahdi Saghari, Pim Gal, Sally Gilbert, et al.
Page
of 2